Prasol Chemicals IPO Details: Key Dates, Price Band & Investment Overview

By Wealthova | Last Updated: September 3, 2026

Prasol Chemicals Limited, a prominent manufacturer of specialty chemicals in India, is gearing up to make its primary market debut with an upcoming ₹500.00 Crore mainboard IPO. Known for its robust portfolio of over 150 specialty chemical products—spanning acetone-based and phosphorus-based derivatives—the company serves critical, high-growth sectors including agrochemicals, pharmaceuticals, personal care, lubricants, and performance materials. Bolstered by a scalable, export-driven model, the company is a Government of India certified 3-star export house operating a sprawling global distribution network that serves clients across 69 countries. The subscription window for this book-built issue opens on September 8 and closes on September 10, 2026. The price band is set between ₹643 to ₹676 per equity share, comprising a fresh issue of ₹80.00 Crore alongside a massive Offer for Sale (OFS) component of ₹420.00 Crore by the promoter group and existing shareholders. The company plans to utilize the fresh capital primarily to prepay or repay existing borrowings to deleverage its balance sheet, alongside funding working capital requirements and general corporate purposes. Set to list on the BSE and NSE platforms, market participants are closely watching this globally integrated specialty chemical player. Below, we break down the financial health, industry risk factors, and our honest Smart Market Insights to help you decide if you should subscribe to this issue!

Incorporated in 1992 and headquartered in Navi Mumbai, Prasol Chemicals Limited is one of India's premier specialty chemical manufacturers. Operating on a highly scalable "import-to-specialty" business model, the company imports crucial raw materials like acetone and yellow phosphorus to synthesize high-value chemical compounds. Prasol holds a dominant market position; it has been the largest importer of acetone in India over recent years and ranks among the top five importers and users of yellow phosphorus domestically.

• Robust Product Portfolio: The company manufactures an extensive catalogue of over 150 specialty chemicals, categorized primarily into acetone-based chemicals (such as diacetone alcohol, isophorone, and hexylene glycol), phosphorus-based chemicals, and other derivatives including surfactants, esters, and acids.
• Diversified End-Use Markets: These chemicals are critical inputs serving over 30 industry verticals. Key sectors include agrochemicals, pharmaceuticals, home and personal care, lubricant and mining additives, as well as paints, inks, construction, and adhesives (PICA).
• Manufacturing Infrastructure: Prasol operates two sprawling manufacturing facilities situated in Khopoli and Mahad (Raigad district, Maharashtra). Combined, these state-of-the-art plants boast an installed production capacity of 87,914 MT per annum.
• Global Distribution & Clientele: As a Government of India certified 3-Star Export House, Prasol caters to over 1,100 clients across 69 countries. Its marquee client base features industry heavyweights like Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, and Croda India.

The Prasol Chemicals IPO comprises a massive total issue size of ₹500.00 Crore. However, the bulk of this issue—₹420.00 Crore—is an Offer for Sale (OFS) allowing existing promoter group shareholders to monetize a portion of their holdings. The remaining ₹80.00 Crore constitutes the Fresh Issue, which the company intends to deploy strategically toward the following objectives:

• Debt Repayment & Deleveraging: A significant portion of the fresh capital is earmarked for the full or partial prepayment of certain outstanding company borrowings, directly aimed at strengthening the balance sheet and reducing financing costs.
• Working Capital Requirements: Funding the incremental working capital needs required to support the day-to-day procurement of highly volatile raw materials (like acetone and yellow phosphorus) and sustain its global operational scale.
• General Corporate Purposes: The residual, unallocated balance from the fresh issue proceeds will be deployed toward standard corporate initiatives and public offer expenses.